DOI:
10.1055/s-00034916
Nervenheilkunde
LinksClose Window
References
Stroup TS, McEvoy JP, Ring KD, Hamer RH, LaVange LM, Swartz MS. et al.
A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: Comparison of antipsychotics for metabolic problems (CAMP).
Am J Psychiatry 2017;
168 (09) 947-956.
We do not assume any responsibility for the contents of the web pages of other providers.